Various conclusions were raised, such as RNF43 being overexpressed in liver cancers [8], to correlate with gastric and clear cell renal cancer patient survival [11–13], or to be lost in a subset of gastric and colorectal cancers [9, 10]. This evidence concerns the gene RNF43 and clear cell renal carcinoma.